Innovation Pharmaceuticals Inc (IPIX)

[TheDane]

When the Aspire deal was announced in late June it made it seem like within three months we’d be sitting in the $5 to $10 range. A sure thing! Except for the waiting, what could be the problem. As we know from painful lesson after painful lesson, nothing is a sure thing. Something always comes up. Except for the possible failure to meet the Sept. 30 deadline for he Aspire deal I can’t see where anything else has changed but for the addition of the Term Sheet in August. HOW CAN THAT BE BAD?

Now the stock is back where it was before the Aspire deal.